Biopharmaceuticals

A Global Market Overview

Product Code INX00007
Publication Date April 2010
Publisher Industry Experts
Product Type Report
Pages 240
ISBN Number not applicable
Change currency
PDF £2,960.00 €3,565 $4,681 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Biopharmaceuticals

A Global Market Overview

Intense research efforts made biopharmaceuticals the most successful products in various therapeutic areas such as Neurology, Infectious Diseases, Cardiovascular, Oncology etc. Undoubtedly, all the major pharmaceuticals are, now, engaged in doing research for new biopharmaceutical active ingredients. Biopharma active ingredients are containing in about 50% of the newly approved drugs. The future of biopharmaceuticals is to be projected bright as the market share is growing gradually. In terms of market revenue, out of total pharma market the biopharmaceutical products were accounted for about 10% in 2006 and are projected to account for about 15% by 2015.

Biopharmaceutical products analyzed in this study comprise Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, Granulocyte-Colony Stimulating Factor, Recombinant Human Insulin, Interferons, Human Growth Hormones and Other. The report also analyzes the market for biopharmaceutical therapeutic areas including Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other.

The global market for biopharmaceuticals is projected to reach US$182.5 billion by 2015, registering a CAGR of 12.4% during the period 2006-2015. The study includes 131 charts (includes a data table and graphical representation for each chart), supported with meaningful and easy to understand graphical presentation, of market numbers. The statistical tables represent the data for the global market value in USD by geographic regions and the product segments.

The report analyses the biopharmaceuticals market for global and the regional markets including North America, Western Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 10 independent countries across North America - the United States and Canada; Europe - Germany, The United Kingdom, France, Italy and Spain; Asia-Pacific - Japan, China and India.

This study profiles 53 key global players and 87 major players across North America - 37; Western Europe - 18; Asia-Pacific - 30; and Rest of World - 2. The report also provides the listing of the companies engaged in research, technology development, manufacturing and the supply of biopharmaceuticals. The global list of companies covers addresses, contact numbers and the website addresses of 382 companies.

Contents

  • 1. GLOBAL MARKET PERSPECTIVE
    • 1.1 Introduction
    • 1.2 Product Segmentation
      • 1.2.1 Monoclonal Antibodies
      • 1.2.2 Biotechnology Vaccines
      • 1.2.3 Erythropoietin
        • 1.2.3.1 Therapeutic Application
      • 1.2.4 Granulocyte-Colony Stimulating Factor
        • 1.2.4.1 Therapeutic Application
      • 1.2.5 Recombinant Human Insulin
      • 1.2.6 Interferons
      • 1.2.7 Human Growth Hormones
        • 1.2.7.1 Therapeutic Application
          • Anti-Aging Agent
          • Athletic Advantages
          • Side Effects
    • 1.3 Application Analysis
      • 1.3.1 End use Markets for Biopharmaceutical Products
      • 1.3.2 Top-25 Biopharmaceutical Blockbuster Drugs
    • 1.4 Market Trends
      • 1.4.1 Big Pharma Companies to Adopt Virtual Pharma Model for Faster Lead Time
      • 1.4.2 Biopharmaceutical Research Network for Producing Monoclonal Antibodies
      • 1.4.3 European Biopharmaceutical Enterprises to Establish European Biopharmaceutical Innovation Fund
      • 1.4.4 Government Policy to Boost Biopharmaceuticals market in China
      • 1.4.5 Future Looks Bright for Indian Biopharmaceuticals Market
    • 1.5 Key Global Players
    • 1.6 Key Business Trends
      • Pharmaxis Takeover Topigen pharma
      • Astrazeneca Settles Patent Agreement with Teva Pharmaceuticals
      • Molecular Insight Pharmaceuticals reduces personnel to synchronize operations
      • Keryx concludes SPA agreement for Phase III clinical trial for Zerenex
      • Merz to Bag BioForm Medical
      • Anika acquires Fidia Advanced Biopolymers
      • Teva-KOWA to acquire stake in Taisho Pharmaceutical
      • Novartis Acquires Corthera Inc
      • AstraZeneca acquires Novexel
      • Array BioPharma Partners with Amgen for Type 2 Diabetes
      • BD acquires HandyLab
      • D-Pharm collaborates with Wanbang Biopharmaceuticals
      • GPC Biotech AG merges with Agennix AG
      • China Biopharmaceuticals merges with NeoStem
      • Bio-Rad signs partnership with Biotest AG for diagnostics
      • Sanofi-Aventis Acquires France based FOVEA
      • Sandoz Closes acquisition of EBEWE Pharma
      • Sanofi-Aventis Acquires Merck's Interest in Merial
      • Johnson & Johnson acquires Cougar Biotechnology
      • Baxter signs agreement with Edwards Life sciences for CRRT
      • MannKind acquires insulin assets from Pfizer
      • Alder expands collaboration with Schering-Plough
      • Akela Pharma Merges with Nventa Biopharmaceuticals
      • Takeda acquires IDM Pharma
      • GVK Biosciences Signs Clinical Research Partnership with Excel Pharma
      • Acquisition of Medley strengthens Sanofi-Aventis position in Brazil
      • Kendrick acquisition reinforces Sanofi's emerging market maneuver
      • Roche acquires Genentech
      • Johnson & Johnson takes over Mentor Corporation
      • Johnson & Johnson acquires Omrix Biopharmaceuticals Inc.
      • Teva acquires Barr
      • GlaxoSmithKline acquires BMS Pakistan
      • Roche signs agreement to takeover Memory Pharmaceuticals
      • Lilly acquires ImClone Systems
      • Acquisition of Alvedon boosts GSK's analgesic portfolio
      • GSK acquires Genelabs Technologies
      • Novartis Takeover Nektar
      • GSK purchase of Laclede's Biotene
      • Sanofi Pasteur Acquires Acambis
      • Lilly takes over SGX
      • Bayer acquires preclinical anti-cancer program from Nycomed
      • Thermo Fisher takes over FIBERLite Centrifuge
      • Teva Bags Bentley Pharmaceuticals
      • Thermo Fisher Acquires Affinity BioReagents
      • Intas Biopharma Bags Biologisc Process Development
      • Boehringer Ingelheim acquires Actimis Pharmaceuticals
      • Itero Biopharma collaborates with Biological E. Ltd.
      • GVK Bio signs Pact with Wyeth Pharmaceuticals for drug discovery
      • Takeda acquires Millennium
      • BD Acquires Cytopeia
      • DOR BioPharma Signs Development license agreement with Harvard
      • Abbott Forms Joint Venture with Takeda
      • Takeda acquires Paradigm Therapeutics
      • Thermo Fisher acquires Finnzymes
      • Dr. Reddy's completes two acquisitions
      • EUSA Pharma Acquires Cytogen
      • Roche acquires Piramed
      • Dr. Reddy's Bags Italian Jet Generici Srl.
      • AVI BioPharma acquires Ercole Biotech
      • Teva acquires CoGenesys
      • Roche bullish on biopharmaceuticals
      • GlaxoSmithKline acquires Reliant Pharmaceuticals
      • Amgen acquires Ilypsa
      • Amgen takes over Alantos
    • 1.7 Key Product Trends
      • FDA Approves Quick Review for Keryx treatment
      • Cipla Introduces generic drug to treat H1N1
      • Glenmark Generics (Europe) launches its first four products for the UK market
      • Keryx Gains orphan drug status for KRX-040
      • Promius Pharma releases Promiseb™
      • Amgen to partner GlaxoSmithKline to commercialize denosumab in Europe
      • Bayer gains entitlement to Bioton's insulin SciLin®
      • Bio-Rad announces Bio-Plex Pro
      • Glenmark Unveils Azathioprine in the US.
      • Promius Introduces EPICERAM®
      • Biocon and Abraxis Bioscience Itroduces Abraxane in India
      • Glenmark Generics launches Tablet for Hypertension
      • BD Biosciences launches high-performance calcium dye assay kit
    • 1.8 Global Market Overview
      • 1.8.1 Market Overview by Biopharmaceutical Product Segment
      • 1.8.2 Biopharmaceutical Product Market Overview by Global Region
        • 1.8.2.1 Monoclonal Antibodies
        • 1.8.2.2 Biotech Vaccines
        • 1.8.2.3 Erythropoietin
        • 1.8.2.4 Granulocyte-Colony Stimulating Factor
        • 1.8.2.5 Recombinant Human Insulin
        • 1.8.2.6 Interferons
        • 1.8.2.7 Human Growth Hormones
        • 1.8.2.8 Other Biopharmaceuticals
      • 1.8.3 Biopharmaceutical Therapeutic Market Overview by Global Region
        • 1.8.3.1 Oncology
        • 1.8.3.2 Neurology
        • 1.8.3.3 Diabetes
        • 1.8.3.4 Infectious Diseases
        • 1.8.3.5 Cardiovascular
        • 1.8.3.6 Other Disease Areas
  • 2. REGIONAL MARKET PERSPECTIVE
    • 2.1 Regional Market Overview
      • 2.1.1 North America
        • 2.1.1.2 Market Overview by North American Region
        • 2.1.1.3 Market Overview by Biopharmaceutical Product
        • 2.1.1.4 Market Overview by Biopharmaceutical Therapeutic Area
        • 2.1.1.5 Biopharmaceutical Product Market Overview by North American Region
          • Monoclonal Antibodies
          • Biotech Vaccines
          • Erythropoietin
          • Granulocyte-Colony Stimulating Factor
          • Recombinant Human Insulin
          • Interferons
          • Human Growth Hormones
          • Other Biopharmaceuticals
        • 2.1.1.6 Major Market Players
          • Abbott Laboratories (USA)
          • Accentia Biopharmaceuticals, Inc. (USA)
          • Advanced Life Sciences, Inc. (USA)
          • Alder Biopharmaceuticals, Inc. (USA)
          • Alexion Pharma (USA)
          • Ambrilia Biopharma Inc. (USA)
          • Amgen (USA)
          • Analytical Biological Services Inc. (USA)
          • Array BioPharma (USA)
          • Astellas Pharma (USA)
          • Atlanta Biologicals, Inc. (USA)
          • AVI BioPharma (USA)
          • Baxter Bioscience Corporation (USA)
          • BD Biosciences (USA)
          • Biodel Inc. (USA)
          • Biogen Idec (USA)
          • Bio-Rad Laboratories, Inc. (USA)
          • DNA Gateway International, Inc. (USA)
          • Eli Lilly (USA)
          • EUSA Pharma (USA)
          • Genentech (USA)
          • Genzyme (USA)
          • Helix BioPharma Corp. (USA)
          • Hemispherx Biopharma, Inc. (USA)
          • IBI International LLC (USA)
          • Johnson & Johnson's (USA)
          • Millipore Corporation (USA)
          • Neurobiological Technologies, Inc. (USA)
          • Novozymes Biopharma (USA)
          • OSI Pharmaceuticals, Inc. (USA)
          • Pfizer Inc. (USA)
          • Procter & Gamble Pharmaceuticals (USA)
          • Provenance BioPharmaceuticals (USA)
          • Sigma-Aldrich Corporation (USA)
          • Soligenix, Inc. (USA)
          • ZymoGenetics (USA)
          • Pacgen Biopharmaceuticals Corporation (Canada)
        • 2.1.1.7 North American Market Overview by Country
          • The United States
          • Canada
      • 2.1.2 Western Europe
        • 2.1.2.1 Market Overview by Western Europe Region
        • 2.1.2.3 Market Overview by Biopharmaceutical Product
        • 2.1.2.3 Market Overview by Biopharmaceutical Therapeutic Area
        • 2.1.2.4 Biopharmaceutical Product Market Overview by Western Europe Region
          • Monoclonal Antibodies
          • Biotech Vaccines
          • Erythropoietin
          • Granulocyte-Colony Stimulating Factor
          • Recombinant Human Insulin
          • Interferons
          • Human Growth Hormones
          • Other Biopharmaceuticals
        • 2.1.2.5 Major Market Players
          • Agennix AG (Germany)
          • AstraZeneca (United Kingdom)
          • Bayer AG (Germany)
          • Boehringer Ingelheim (Germany)
          • Bristol-Myers Squibb Belgium NV (Belgium)
          • CellGenix Technologie Transfer GmbH (Germany)
          • GlaxoSmithKline Pharmaceuticals Limited (United Kingdom)
          • Merck Serono S.A (Switzerland)
          • Novartis (Switzerland)
          • Novo Nordisk (Denmark)
          • PromoCell GmbH (Germany)
          • Pronova BioPharma (Norway)
          • Roche (Switzerland)
          • Sandoz Biogenerics (Germany)
          • Sanofi-Aventis (France)
          • Schering Ag (Germany)
          • Solvay Pharma & Cie (Belgium)
          • UCB S.A. (Belgium)
        • 2.1.2.6 Western Europe Market Overview by Country
          • Germany
          • The United Kingdom
          • France
          • Italy
          • Spain
          • Rest of Western Europe
      • 2.1.3 Asia-Pacific
        • 2.1.3.1 Market Overview by Asia-Pacific Region
        • 2.1.3.2 Market Overview by Biopharmaceutical Product
        • 2.1.3.3 Market Overview by Biopharmaceutical Therapeutic Area
        • 2.1.3.4 Biopharmaceutical Product Market Overview by Asia-Pacific Region
          • Monoclonal Antibodies
          • Biotech Vaccines
          • Erythropoietin
          • Granulocyte-Colony Stimulating Factor
          • Recombinant Human Insulin
          • Interferons
          • Human Growth Hormones
          • Other Biopharmaceuticals
        • 2.1.3.5 Major Market Players
          • Aurobindo Pharma Ltd. (India)
          • Aventis Pharma Limited (India)
          • Beijing SL Pharmaceutical Co., Ltd. (China)
          • Beijing Tiantan Biological Products Co., Ltd. (China)
          • Biocon Ltd. (India)
          • Biological E Limited (India)
          • Bukwang Pharma (South Korea)
          • CellResearchCorp (Singapore)
          • Cipla Ltd (India)
          • Da An Gene Co., Ltd (China)
          • Daiichi Sankyo Ltd. (Japan)
          • Dr. Reddy's Laboratories (India)
          • Glenmark Pharmaceuticals Ltd. (India)
          • GVK BIO (India)
          • Hualan Biological Engineering Inc. (China)
          • i-DNA Biotechnology (Singapore)
          • LG Life Sciences (South Korea)
          • Panacea Biotech Ltd. (India)
          • Ranbaxy Laboratories Limited (India)
          • Reliance Life Sciences (India)
          • RPG Life Sciences Ltd. (India)
          • SciGen (Singapore)
          • Shanghai Institute of Biological Products (China)
          • Shantha Biotechniques Ltd. (India)
          • Shenzhen Neptunus Bioengineering Co., Ltd. (China)
          • Sun Pharmaceutical Industries Ltd. (India)
          • Suven Life Sciences Ltd. (India)
          • Takeda (Japan)
          • Torrent Pharmaceuticals Ltd. (India)
          • Zydus Cadila Ltd. (India)
        • 2.1.3.6 Asia-Pacific Market Overview by Country
          • Japan
          • China
          • India
          • Rest of Asia-Pacific
      • 2.1.4 Rest of World
        • 2.1.4.1 Market Overview by Biopharmaceutical Product
        • 2.1.4.2 Market Overview by Biopharmaceutical Therapeutic Area
        • 2.1.4.3 Major Market Players
          • D-Pharm Ltd. (Israel)
          • Teva Pharmaceutical Industries (Israel)
  • 3. GUIDE TO THE INDUSTRY
    • 3.1 North America
      • 3.1.1 United States
      • 3.1.2 Canada
    • 3.2 Europe
      • 3.2.1 Germany
      • 3.2.2 United Kingdom
      • 3.2.3 France
      • 3.2.4 Belgium
      • 3.2.5 Denmark
      • 3.2.6 Ireland
      • 3.2.7 Norway
      • 3.2.8 Sweden
      • 3.2.9 Switzerland
      • 3.2.10 The Netherlands
    • 3.3 Asia-Pacific
      • 3.3.1 Japan
      • 3.3.2 China
      • 3.3.3 India
      • 3.3.4 Australia
      • 3.3.5 Hong Kong
      • 3.3.6 Indonesia
      • 3.3.7 Malaysia
      • 3.3.8 Singapore
      • 3.3.9 South Korea
      • 3.3.10 Taiwan
    • 3.4 Rest of World
      • 3.4.1 Brazil
      • 3.4.2 Israel
  • 4. ANNEXURE
    • 4.1 Research Methodology
    • 4.2 The Questionnaire
    • 4.3 Feedback
    • Charts & Graphs
  • GLOBAL MARKET PERSPECTIVE
    • Chart 1: Global Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million
    • Chart 2: Glance at 2006, 2010 and 2015 Global Biopharmaceuticals Market Share (%) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other
    • Chart 3: Global Sales of Blockbuster Drugs (2008 & 2009) in USD Million
    • Chart 4: Global Biopharmaceuticals Market Analysis (2006-2015) in USD Million
    • Chart 5: Global Biopharmaceuticals Market Analysis (2006-2015) by Product Segment Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 6: Glance at 2006, 2010 and 2015 Global Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
    • Chart 7: Global Monoclonal Antibodies Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 8: Glance at 2006, 2010 and 2015 Global Monoclonal Antibodies Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
    • Chart 9: Global Biotech Vaccines Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 10: Glance at 2006, 2010 and 2015 Global Biotech Vaccines Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
    • Chart 11: Global Erythropoietin Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 12: Glance at 2006, 2010 and 2015 Global Erythropoietin Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
    • Chart 13: Global G-CSF Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 14: Glance at 2006, 2010 and 2015 Global G-CSF Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
    • Chart 15: Global Monoclonal Antibodies Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 16: Glance at 2006, 2010 and 2015 Global Monoclonal Antibodies Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
    • Chart 17: Global Interferons Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 18: Glance at 2006, 2010 and 2015 Global Interferons Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
    • Chart 19: Global HG Hormones Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 20: Glance at 2006, 2010 and 2015 Global HG Hormones Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
    • Chart 21: Global Other Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 22: Glance at 2006, 2010 and 2015 Global Other Biopharmaceuticals Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
    • Chart 23: Global Biopharmaceuticals Market Analysis (2006-2015) in Oncology by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 24: Glance at 2006, 2010 and 2015 Global Oncology Market Share (%) of Biopharmaceuticals by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
    • Chart 25: Global Biopharmaceuticals Market Analysis (2006-2015) in Neurology by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 26: Glance at 2006, 2010 and 2015 Global Neurology Market Share (%) of Biopharmaceuticals by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
    • Chart 27: Global Biopharmaceuticals Market Analysis (2006-2015) in Diabetes by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 28: Glance at 2006, 2010 and 2015 Global Diabetes Market Share (%) of Biopharmaceuticals by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
    • Chart 29: Global Biopharmaceuticals Market Analysis (2006-2015) in Infectious Diseases by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 30: Glance at 2006, 2010 and 2015 Global Infectious Diseases Market Share (%) of Biopharmaceuticals by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
    • Chart 31: Global Biopharmaceuticals Market Analysis (2006-2015) in Cardiovascular by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 32: Glance at 2006, 2010 and 2015 Global Cardiovascular Market Share (%) of Biopharmaceuticals by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
    • Chart 33: Global Biopharmaceuticals Market Analysis (2006-2015) in Other Disease Areas by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 34: Glance at 2006, 2010 and 2015 Global Other Disease Areas Market Share (%) of Biopharmaceuticals by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
  • REGIONAL MARKET PERSPECTIVE
    • Chart 35: The Projection of Largest Regions in terms of Market Growth for Biopharmaceuticals by Geography - Asia-Pacific, Europe and North America
    • Chart 36: Global Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World in USD Million
    • Chart 37: Glance at 2006, 2010 and 2015 Global Biopharmaceuticals Market Share (%) by Geographic Region - North America, Western Europe, Asia-Pacific and Rest of World
  • NORTHE AMERICA
    • Chart 38: North American Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million
    • Chart 39: Glance at 2006, 2010 and 2015 North American Biopharmaceuticals Market Share (%) by Geographic Region - United States and Canada
    • Chart 40: North American Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 41: Glance at 2006, 2010 and 2015 North American Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin,Interferons, HG Hormones and Other
    • Chart 42: North American Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million
    • Chart 43: Glance at 2006, 2010 and 2015 North American Biopharmaceuticals Market Share (%) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other
    • Chart 44: North American Monoclonal Antibodies Market (2006-2015) by Geographic Region - United States and Canada in USD Million
    • Chart 45: Glance at 2006, 2010 and 2015 North American Monoclonal Antibodies Market Share (%) by Geographic Region - United States and Canada
    • Chart 46: North American Biotech Vaccines Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million
    • Chart 47: Glance at 2006, 2010 and 2015 North American Biotech Vaccines Market Share (%) by Geographic Region - United States and Canada
    • Chart 48: North American Erythropoietin Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million
    • Chart 49: Glance at 2006, 2010 and 2015 North American Erythropoietin Market Share (%) by Geographic Region - United States and Canada
    • Chart 50: North American G-CSF Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million
    • Chart 51: Glance at 2006, 2010 and 2015 North American G-CSF Market Share (%) by Geographic Region - United States and Canada
    • Chart 52: North American RH Insulin Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million
    • Chart 53: Glance at 2006, 2010 and 2015 North American RH Insulin Market Share (%) by Geographic Region - United States and Canada
    • Chart 54: North American Interferons Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million
    • Chart 55: Glance at 2006, 2010 and 2015 North American Interferons Market Share (%) by Geographic Region - United States and Canada
    • Chart 56: North American HG Hormones Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million
    • Chart 57: Glance at 2006, 2010 and 2015 North American HG Hormones Market Share (%) by Geographic Region - United States and Canada
    • Chart 58: North American Other Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - United States and Canada in USD Million
    • Chart 59: Glance at 2006, 2010 and 2015 North American Other Biopharmaceuticals Market Share (%) by Geographic Region -United States and Canada
  • The United States
    • Chart 60: United States Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 61: Glance at 2006, 2010 and 2015 United States Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
  • Canada
    • Chart 62: Canadian Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 63: Glance at 2006, 2010 and 2015 Canadian Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
  • WESTERN EUROPE
    • Chart 64: Western Europe Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
    • Chart 65: Glance at 2006, 2010 and 2015 Western Europe Biopharmaceuticals Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE
    • Chart 66: Western Europe Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 67: Glance at 2006, 2010 and 2015 Western Europe Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
    • Chart 68: Western Europe Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million
    • Chart 69: Glance at 2006, 2010 and 2015 Western Europe Biopharmaceuticals Market Share (%) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other
    • Chart 70: Western Europe Monoclonal Antibodies Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
    • Chart 71: Glance at 2006, 2010 and 2015 Western Europe Monoclonal Antibodies Market Share (%) by Geographic Region -Germany, United Kingdom, France, Italy, Spain and Rest of WE
    • Chart 72: Western Europe Biotech Vaccines Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
    • Chart 73: Glance at 2006, 2010 and 2015 Western Europe Biotech Vaccines Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE
    • Chart 74: Western Europe Erythropoietin Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
    • Chart 75: Glance at 2006, 2010 and 2015 Western Europe Erythropoietin Market Share (%) by Geographic Region -Germany, United Kingdom France, Italy, Spain and Rest of WE
    • Chart 76: Western Europe G-CSF Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
    • Chart 77: Glance at 2006, 2010 and 2015 Western Europe G-CSF Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE
    • Chart 78: Western Europe RH Insulin Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
    • Chart 79: Glance at 2006, 2010 and 2015 Western Europe RH Insulin Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE
    • Chart 80: Western Europe Interferons Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
    • Chart 81: Glance at 2006, 2010 and 2015 Western Europe Interferons Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE
    • Chart 82: Western Europe HG Hormones Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
    • Chart 83: Glance at 2006, 2010 and 2015 Western Europe HG Hormones Market Share (%) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE
    • Chart 84: Western Europe Other Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - Germany, United Kingdom, France, Italy, Spain and Rest of WE in USD Million
    • Chart 85: Glance at 2006, 2010 and 2015 Western Europe Other Biopharmaceuticals Market Share (%) by Geographic Region -Germany, United Kingdom, France, Italy, Spain and Rest of WE
  • Germany
    • Chart 86: German Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 87: Glance at 2006, 2010 and 2015 German Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
  • The United Kingdom
    • Chart 88: United Kingdom Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 89: Glance at 2006, 2010 and 2015 United Kingdom Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
  • France
    • Chart 90: French Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 91: Glance at 2006, 2010 and 2015 French Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
  • Italy
    • Chart 92: Italian Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 93: Glance at 2006, 2010 and 2015 Italian Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
  • Spain
    • Chart 94: Spanish Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 95: Glance at 2006, 2010 and 2015 Spanish Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
  • Rest of Western Europe
    • Chart 96: Rest of WE Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 97: Glance at 2006, 2010 and 2015 Rest of WE Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
  • ASIA-PACIFIC
    • Chart 98: Asia-Pacific Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
    • Chart 99: Glance at 2006, 2010 and 2015 Asia-Pacific Biopharmaceuticals Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
    • Chart 100: Asia-Pacific Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 101: Glance at 2006, 2010 and 2015 Asia-Pacific Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
    • Chart 102: Asia-Pacific Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million
    • Chart 103: Glance at 2006, 2010 and 2015 Asia-Pacific Biopharmaceuticals Market Share (%) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other
    • Chart 104: Asia-Pacific Monoclonal Antibodies Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
    • Chart 105: Glance at 2006, 2010 and 2015 Asia-Pacific Monoclonal Antibodies Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
    • Chart 106: Asia-Pacific Biotech Vaccines Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
    • Chart 107: Glance at 2006, 2010 and 2015 Asia-Pacific Biotech Vaccines Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
    • Chart 108: Asia-Pacific Erythropoietin Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
    • Chart 109: Glance at 2006, 2010 and 2015 Asia-Pacific Erythropoietin Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
    • Chart 110: Asia-Pacific G-CSF Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
    • Chart 111: Glance at 2006, 2010 and 2015 Asia-Pacific G-CSF Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
    • Chart 112: Asia-Pacific RH Insulin Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
    • Chart 113: Glance at 2006, 2010 and 2015 Asia-Pacific RH Insulin Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
    • Chart 114: Asia-Pacific Interferons Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
    • Chart 115: Glance at 2006, 2010 and 2015 Asia-Pacific Interferons Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
    • Chart 116: Asia-Pacific HG Hormones Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
    • Chart 117: Glance at 2006, 2010 and 2015 Asia-Pacific HG Hormones Market Share (%) by Geographic Region - Japan, China, India and Rest of Asia-Pacific
    • Chart 118: Asia-Pacific Other Biopharmaceuticals Market Analysis (2006-2015) by Geographic Region - Japan, China, India and Rest of Asia-Pacific in USD Million
    • Chart 119: Glance at 2006, 2010 and 2015 Asia-Pacific Other Biopharmaceuticals Market Share (%) by Geographic Region -Japan, China, India and Rest of Asia-Pacific
  • Japan
    • Chart 120: Japanese Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 121: Glance at 2006, 2010 and 2015 Japanese Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
  • China
    • Chart 122: Chinese Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 123: Glance at 2006, 2010 and 2015 Chinese Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
  • India
    • Chart 124: Indian Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 125: Glance at 2006, 2010 and 2015 Indian Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons,HG Hormones and Other
  • Rest of Asia-Pacific
    • Chart 126: Rest of Asia-Pacific Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 127: Glance at 2006, 2010 and 2015 Rest of Asia-Pacific Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
  • REST OF WORLD
    • Chart 128: Rest of World Biopharmaceuticals Market Analysis (2006-2015) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other in USD Million
    • Chart 129: Glance at 2006, 2010 and 2015 Rest of World Biopharmaceuticals Market Share (%) by Product Segment - Monoclonal Antibodies, Biotech Vaccines, Erythropoietin, G-CSF, RH Insulin, Interferons, HG Hormones and Other
    • Chart 130: Rest of World Biopharmaceuticals Market Analysis (2006-2015) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other in USD Million
    • Chart 131: Glance at 2006, 2010 and 2015 Rest of World Biopharmaceuticals Market Share (%) by Therapeutic Area - Oncology, Neurology, Diabetes, Infectious Diseases, Cardiovascular and Other
  • Major Global Market Players
    • Abbott Laboratories
    • Alexion Pharma
    • Ambrilia Biopharma Inc.
    • Amgen
    • Analytical Biological Services Inc.
    • AstraZeneca
    • Atlanta Biologicals, Inc.
    • Aventis Pharma Limited
    • AVI BioPharma
    • Baxter Bioscience Corporation
    • Bayer AG
    • BD Biosciences
    • Beijing Tiantan Biological Products Co., Ltd.
    • Biocon Ltd.
    • Biogen Idec
    • Bio-Rad Laboratories, Inc.
    • Boehringer Ingelheim
    • Bristol-Myers Squibb Belgium NV
    • Bukwang Pharma
    • CellResearchCorp
    • Cipla Ltd
    • Daiichi Sankyo Ltd.
    • DNA Gateway International, Inc.
    • Dr. Reddy's Laboratories
    • Eli Lilly
    • Genentech
    • Genzyme
    • GlaxoSmithKline Pharmaceuticals Limited
    • Glenmark Pharmaceuticals Ltd.
    • GVK BIO
    • Helix BioPharma Corp.
    • Hualan Biological Engineering Inc.
    • Johnson & Johnson
    • LG Life Sciences
    • Merck Serono S.A
    • Millipore Corporation
    • Novartis
    • Novo Nordisk
    • OSI Pharmaceuticals, Inc.
    • Pfizer Inc.
    • Procter & Gamble Pharmaceuticals
    • Ranbaxy Laboratories Limited
    • Reliance Life Sciences
    • Roche
    • Sandoz Biogenerics
    • Sanofi-Aventis
    • Schering Ag
    • Shantha Biotechniques Ltd.
    • Sigma-Aldrich Corporation
    • Solvay Pharma & Cie
    • Takeda
    • Teva Pharmaceutical Industries
    • UCB S.A.